GO:0032440 2-alkenal reductase [NAD(P)H] activity

2-alkenal reductase [NAD(P)H] activity (GO:0032440) is a molecular function that catalyzes the NAD(P)H-dependent reduction of reactive 2-alkenal species to their saturated n-alkanal counterparts. The reaction is reversible and follows the stoichiometry n-alkanal + NAD(P)+ = alk-2-enal + NAD(P)H + H+, so the same active site can either detoxify an alkenal or regenerate it depending on the redox state of the cell. This activity is central to the cellular handling of lipid peroxide-derived reactive aldehydes, a class of electrophiles that can modify proteins and nucleic acids. Researchers care about GO:0032440 because reactive aldehydes are a shared downstream consequence of oxidative stress and lipid peroxidation, and their accumulation is linked to membrane damage, protein carbonylation, and cell death. Enzymes that catalyze 2-alkenal reduction therefore act as a metabolic buffer that limits electrophile load. The best-characterized example is the Arabidopsis thaliana NADPH:quinone oxidoreductase P1-zeta-crystallin, which was shown to catalyze the alpha,beta-hydrogenation of 2-alkenals and to detoxify lipid peroxide-derived reactive aldehydes. From a research-methods perspective, GO:0032440 is a tractable enzymatic activity: it can be measured spectrophotometrically by following NAD(P)H consumption, reconstituted with purified enzyme and substrate, and perturbed genetically with CRISPR. This makes it a useful entry point for studies that connect redox metabolism, aldehyde detoxification, and disease-relevant stress responses.

In simple terms, GO:0032440 is the activity of an enzyme that uses NAD(P)H to remove a double bond from a reactive 2-alkenal, converting it into a less reactive saturated aldehyde. The QuickGO definition states: Catalysis of the reaction: n-alkanal + NAD(P)+ = alk-2-enal + NAD(P)H + H+. The term is a molecular_function and carries synonyms including 2-alkenal reductase [NAD(P)+] activity, NAD(P)H-dependent alkenal/one oxidoreductase activity, and n-alkanal:NAD(P)+ 2-oxidoreductase activity. Because the reaction is written as an equilibrium, the enzyme can in principle catalyze either the reduction of an alkenal or the oxidation of an alkanal, depending on substrate and cofactor availability.

GO:0032440 matters because it defines a biochemical safeguard against reactive aldehydes generated during lipid peroxidation. When oxidative stress drives lipid peroxide breakdown, 2-alkenals such as acrolein-type electrophiles can accumulate and covalently modify proteins and nucleic acids. The NAD(P)H-dependent reduction of these alkenals to saturated aldehydes lowers their electrophilic reactivity and is therefore a protective metabolic route. The Arabidopsis P1-zeta-crystallin enzyme provides direct experimental evidence that a single polypeptide can catalyze this alpha,beta-hydrogenation and detoxify lipid peroxide-derived reactive aldehydes. Because the same chemistry is conserved across kingdoms, GO:0032440 is a useful functional annotation for comparative and disease-oriented studies of aldehyde detoxification.

The genes and proteins below are directly or functionally associated with 2-alkenal reductase [NAD(P)H] activity (GO:0032440) and its detoxification of lipid peroxide-derived reactive aldehydes.

The activity described by GO:0032440 is regulated at multiple levels. At the transcriptional level, antioxidant response programs such as Nrf2/NFE2L2 signaling can increase expression of detoxification enzymes that handle reactive aldehydes. At the metabolic level, the availability of NAD(P)H and the rate of lipid peroxide generation determine the flux through alkenal reduction. At the protein level, the Arabidopsis P1-zeta-crystallin enzyme illustrates that a single polypeptide can integrate quinone and alkenal reduction chemistry, suggesting that its activity is tuned by cofactor supply and substrate competition. Because the reaction is reversible, the net direction of flux is also controlled by product removal and by the redox state of the pyridine nucleotide pool.

Reactive aldehydes generated by lipid peroxidation are implicated in oxidative stress-related tissue damage, and enzymes with 2-alkenal reductase activity provide a detoxification route for these species. The Arabidopsis P1-zeta-crystallin enzyme was characterized specifically as a detoxifier of lipid peroxide-derived reactive aldehydes, establishing a mechanistic link between this activity and protection against oxidative damage. In mammalian systems, the same chemistry is relevant to degenerative conditions in which lipid peroxidation outpaces aldehyde clearance.

Ferroptosis is a form of regulated cell death driven by iron-dependent lipid peroxidation, which generates reactive alkenals. Because GO:0032440 catalyzes the reduction of 2-alkenals to less reactive saturated aldehydes, it represents a potential brake on the electrophilic damage that accompanies ferroptosis. The demonstration that P1-zeta-crystallin detoxifies lipid peroxide-derived reactive aldehydes supports the concept that alkenal reduction is a protective metabolic function.

Reactive aldehydes can act as electrophiles that modify proteins and trigger stress signaling, contributing to inflammatory tissue injury. By converting 2-alkenals to saturated n-alkanals, the activity defined by GO:0032440 reduces the electrophilic burden. The Arabidopsis P1-zeta-crystallin study provides direct biochemical evidence for this detoxication function and supports broader investigation of alkenal-reducing enzymes in inflammatory contexts.

Cancer cells often experience elevated oxidative stress and lipid peroxidation, and their survival can depend on robust aldehyde detoxification. The ability to reduce 2-alkenals to saturated aldehydes may contribute to redox adaptation and therapy resistance. The mechanistic precedent from P1-zeta-crystallin, which catalyzes alpha,beta-hydrogenation of 2-alkenals, provides a template for studying whether tumor cells exploit similar activities.

The most direct way to study GO:0032440 is to measure NAD(P)H consumption spectrophotometrically in the presence of a 2-alkenal substrate. Purified enzyme or cell lysate can be used, and the reaction can be run in either direction depending on the redox conditions chosen. The Arabidopsis P1-zeta-crystallin enzyme was characterized using such biochemical approaches to demonstrate alpha,beta-hydrogenation of 2-alkenals.

CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate genes for 2-alkenal reductase activity. Knockout cells reveal whether a gene is required for alkenal detoxification, while overexpression tests sufficiency. Point mutations can dissect catalytic residues, and tagged knock-ins enable localization and interaction studies.

Mass spectrometry-based lipidomics and aldehyde profiling can quantify the substrates and products of the GO:0032440 reaction in cells and tissues. These methods connect enzyme activity to the broader lipid peroxidation landscape. The characterization of P1-zeta-crystallin as a detoxifier of lipid peroxide-derived reactive aldehydes illustrates how biochemical and analytical approaches can be combined.

Cell viability, protein carbonylation, and oxidative stress markers can be used to test whether 2-alkenal reductase activity protects cells from aldehyde challenge. Comparing wild-type and CRISPR-edited cells under oxidative stress conditions reveals the functional impact of the activity. The detoxication function demonstrated for P1-zeta-crystallin provides a rationale for such phenotypic assays.

Researchers studying 2-alkenal reductase [NAD(P)H] activity-related genes often need to determine whether a candidate gene is causally involved in aldehyde detoxification or is merely correlated with stress responses. Establishing causality requires precise genetic models that can remove, modify, tag, or overexpress the gene of interest in a controlled cellular background. EDITGENE provides these models together with screening and bioinformatics support so that hypotheses about GO:0032440 can be tested rigorously.

GO:0032440, 2-alkenal reductase [NAD(P)H] activity, defines a reversible NAD(P)H-dependent reduction that converts reactive 2-alkenals into saturated n-alkanals. Its best-characterized example, the Arabidopsis thaliana NADPH:quinone oxidoreductase P1-zeta-crystallin, directly demonstrates alpha,beta-hydrogenation of 2-alkenals and detoxication of lipid peroxide-derived reactive aldehydes. This activity is therefore a key node connecting oxidative stress, lipid peroxidation, and cellular protection. For researchers, GO:0032440 offers a clear biochemical readout and a genetically tractable target. Combining enzymatic assays with CRISPR knockout, point-mutation, knock-in, and overexpression models enables rigorous causal testing of candidate genes and their roles in disease-relevant stress responses.